Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001058BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS46001458BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS10018710HBVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30010291HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30017984HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034815HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034816HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034817HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034818HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034819HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB09079
Drug NameNintedanib
Target IDBE0000029
UniProt IDP17948
Regulation Typeinhibitor
PubMed IDs18559524; 31016670
CitationsHilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ: BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 2008 Jun 15;68(12):4774-82. doi: 10.1158/0008-5472.CAN-07-6307.@@Wind S, Schmid U, Freiwald M, Marzin K, Lotz R, Ebner T, Stopfer P, Dallinger C: Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. Clin Pharmacokinet. 2019 Sep;58(9):1131-1147. doi: 10.1007/s40262-019-00766-0.
GroupsApproved
Direct ClassificationIndolecarboxylic acids
SMILESCOC(=O)C1=CC=C2C(NC(=O)C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Pathways
PharmGKB
ChEMBLCHEMBL502835